Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis

Previous studies have suggested that the Lactobacillus plantarum bacteria strain could be effective in ulcerative colitis (UC) management. However, its effects are strain-specific and the related mechanisms for its attenuating effects on UC remain unclear. This study aimed to elucidate the underlyin...

Full description

Bibliographic Details
Main Authors: Peng Yu, Chuxin Ke, Jiaxin Guo, Xiuling Zhang, Bailiang Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.575173/full
_version_ 1818455142930841600
author Peng Yu
Chuxin Ke
Jiaxin Guo
Xiuling Zhang
Bailiang Li
Bailiang Li
author_facet Peng Yu
Chuxin Ke
Jiaxin Guo
Xiuling Zhang
Bailiang Li
Bailiang Li
author_sort Peng Yu
collection DOAJ
description Previous studies have suggested that the Lactobacillus plantarum bacteria strain could be effective in ulcerative colitis (UC) management. However, its effects are strain-specific and the related mechanisms for its attenuating effects on UC remain unclear. This study aimed to elucidate the underlying mechanisms for the protective effect of L. plantarum on UC. Firstly, 15 L. plantarum strains were screened for potential probiotic characteristics with good tolerance to simulated human gastrointestinal transit and adhesion. Secondly, the inflammatory response of selected strains to the Caco-2 cells induced by lipopolysaccharide (LPS) was measured. Finally, an in vivo mouse model induced by dextran sulfate sodium (DSS) was used to assess the beneficial effects and likely action mechanisms the successfully screened in vitro strain, L. plantarum L15. In vitro results showed that L. plantarum L15 possessed the highest gastrointestinal transit tolerance, adhesion and reduction of pro-inflammatory abilities compared to the other screened strains. In vivo, high dose of L. plantarum L15 supplementation increased the body weight, colon length and anti-inflammatory cytokine production. Pro-inflammatory cytokine production, disease activity index (DAI) levels and myeloperoxidase (MPO) parameters decreased using this strain. In addition, L. plantarum L15 alleviated the histopathological changes in colon, modulated the gut microbiota, and decreased LPS secretion. The activities of this strain down-regulated the expression of TLR4 and MyD88 genes as well as genes associated with NF-κB signaling pathway. Our findings present L. plantarum L15 as a new probiotic, with promising application for UC management.
first_indexed 2024-12-14T22:06:05Z
format Article
id doaj.art-e6cee7802d4f49ad9219be789a4c5686
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-14T22:06:05Z
publishDate 2020-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-e6cee7802d4f49ad9219be789a4c56862022-12-21T22:45:52ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-10-011110.3389/fimmu.2020.575173575173Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota DysbiosisPeng Yu0Chuxin Ke1Jiaxin Guo2Xiuling Zhang3Bailiang Li4Bailiang Li5College of Food Science, Northeast Agricultural University, Harbin, ChinaCollege of Food Science, Northeast Agricultural University, Harbin, ChinaCollege of Food Science, Northeast Agricultural University, Harbin, ChinaCollege of Food Science, Northeast Agricultural University, Harbin, ChinaCollege of Food Science, Northeast Agricultural University, Harbin, ChinaKey Laboratory of Dairy Science, Ministry of Education, Northeast Agricultural University, Harbin, ChinaPrevious studies have suggested that the Lactobacillus plantarum bacteria strain could be effective in ulcerative colitis (UC) management. However, its effects are strain-specific and the related mechanisms for its attenuating effects on UC remain unclear. This study aimed to elucidate the underlying mechanisms for the protective effect of L. plantarum on UC. Firstly, 15 L. plantarum strains were screened for potential probiotic characteristics with good tolerance to simulated human gastrointestinal transit and adhesion. Secondly, the inflammatory response of selected strains to the Caco-2 cells induced by lipopolysaccharide (LPS) was measured. Finally, an in vivo mouse model induced by dextran sulfate sodium (DSS) was used to assess the beneficial effects and likely action mechanisms the successfully screened in vitro strain, L. plantarum L15. In vitro results showed that L. plantarum L15 possessed the highest gastrointestinal transit tolerance, adhesion and reduction of pro-inflammatory abilities compared to the other screened strains. In vivo, high dose of L. plantarum L15 supplementation increased the body weight, colon length and anti-inflammatory cytokine production. Pro-inflammatory cytokine production, disease activity index (DAI) levels and myeloperoxidase (MPO) parameters decreased using this strain. In addition, L. plantarum L15 alleviated the histopathological changes in colon, modulated the gut microbiota, and decreased LPS secretion. The activities of this strain down-regulated the expression of TLR4 and MyD88 genes as well as genes associated with NF-κB signaling pathway. Our findings present L. plantarum L15 as a new probiotic, with promising application for UC management.https://www.frontiersin.org/article/10.3389/fimmu.2020.575173/fullLactobacillus plantarumDSS-colitisgut microbiotalipopolysaccharide (LPS)NF-κB signaling
spellingShingle Peng Yu
Chuxin Ke
Jiaxin Guo
Xiuling Zhang
Bailiang Li
Bailiang Li
Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis
Frontiers in Immunology
Lactobacillus plantarum
DSS-colitis
gut microbiota
lipopolysaccharide (LPS)
NF-κB signaling
title Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis
title_full Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis
title_fullStr Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis
title_full_unstemmed Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis
title_short Lactobacillus plantarum L15 Alleviates Colitis by Inhibiting LPS-Mediated NF-κB Activation and Ameliorates DSS-Induced Gut Microbiota Dysbiosis
title_sort lactobacillus plantarum l15 alleviates colitis by inhibiting lps mediated nf κb activation and ameliorates dss induced gut microbiota dysbiosis
topic Lactobacillus plantarum
DSS-colitis
gut microbiota
lipopolysaccharide (LPS)
NF-κB signaling
url https://www.frontiersin.org/article/10.3389/fimmu.2020.575173/full
work_keys_str_mv AT pengyu lactobacillusplantaruml15alleviatescolitisbyinhibitinglpsmediatednfkbactivationandamelioratesdssinducedgutmicrobiotadysbiosis
AT chuxinke lactobacillusplantaruml15alleviatescolitisbyinhibitinglpsmediatednfkbactivationandamelioratesdssinducedgutmicrobiotadysbiosis
AT jiaxinguo lactobacillusplantaruml15alleviatescolitisbyinhibitinglpsmediatednfkbactivationandamelioratesdssinducedgutmicrobiotadysbiosis
AT xiulingzhang lactobacillusplantaruml15alleviatescolitisbyinhibitinglpsmediatednfkbactivationandamelioratesdssinducedgutmicrobiotadysbiosis
AT bailiangli lactobacillusplantaruml15alleviatescolitisbyinhibitinglpsmediatednfkbactivationandamelioratesdssinducedgutmicrobiotadysbiosis
AT bailiangli lactobacillusplantaruml15alleviatescolitisbyinhibitinglpsmediatednfkbactivationandamelioratesdssinducedgutmicrobiotadysbiosis